Chung SYoung, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov EV, Puspita L, Valiulahi P, Sulzer D, Milner TA et al..
2016.
Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.. Stem Cell Reports. 7(4):664-677.
Esmaeili MA, Yadav S, Gupta RKr, Waggoner GR, DeLoach A, Calingasan NY, M Beal F, Kiaei M.
2016.
Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo.. Hum Mol Genet. 25(2):317-27.
Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D, Katovich K, Mehta H, Patenaude B, Ramakrishnan C et al..
2016.
Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior.. Science. 351(6268):aac9698.
Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D, Katovich K, Mehta H, Patenaude B, Ramakrishnan C et al..
2016.
Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior.. Science. 351(6268):aac9698.
Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D, Katovich K, Mehta H, Patenaude B, Ramakrishnan C et al..
2016.
Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior.. Science. 351(6268):aac9698.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.
2016.
Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.
2016.
Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Kuceyeski A, Navi BB, Kamel H, Raj A, Relkin N, Toglia J, Iadecola C, O'Dell M.
2016.
Structural connectome disruption at baseline predicts 6-months post-stroke outcome.. Hum Brain Mapp. 37(7):2587-601.
Kuceyeski A, Navi BB, Kamel H, Raj A, Relkin N, Toglia J, Iadecola C, O'Dell M.
2016.
Structural connectome disruption at baseline predicts 6-months post-stroke outcome.. Hum Brain Mapp. 37(7):2587-601.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.
2016.
A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.
2016.
A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Liu W, Zhao L, Blackman B, Parmar M, Wong MYing, Woo T, Yu F, Chiuchiolo MJ, Sondhi D, Kaminsky SM et al..
2016.
Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.. J Neurosci. 36(49):12425-12435.